A US task force which has enforced sanctions on Russian oligarchs since the 2022 Ukraine invasion has been disbanded by ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

As the ‘miracle’ drugs sweep the globe, pubs, bars and drinks manufacturers are scrambling to cope with an unexpected side ...

Jackson’s new state-appointed court system is up and running. Mississippi Supreme Court Chief Justice Michael K. Randolph ...

(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from ...

Maxim initiated coverage of Kazia Therapeutics (KZIA) with a Buy rating and $3 price target The company’s lead asset is paxalisib, a potent, ...

Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target ...

On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

We compiled today’s newsletter using reporting from Jonathan Tannenwald, Ariel Simpson, Gabriela Carroll, Sam Morris, Johnny ...

An international team of researchers, led by the University of Glasgow, hopes to find new ways to target opioid addiction ...